Karo Healthcare to be Acquired by KKR from EQT

EQT has agreed to sell Karo Healthcare, a leading pan-European consumer health platform, to global private equity firm KKR. Under EQT's ownership since 2019, Karo evolved from a Nordic specialty pharma business into a major player on the European consumer healthcare scene, growing its sales fourfold through strategic acquisitions and investments in digitalization and commercial capabilities. The acquisition by KKR is expected to drive further innovation, expansion, and brand growth for Karo, leveraging KKR's sector expertise and global network. The transition aligns with Karo's ambition to continue its strategic growth, enhance its brand reach, and expand its geographic footprint. The transaction, subject to regulatory approvals, is anticipated to close within the upcoming months. Key advisors for this deal were Morgan Stanley, Jeffries, White & Case, PwC for EQT, and Citigroup for KKR.